Login / Signup

The clinical significance of monitoring the expression of the SIL-TAL1 fusion gene in T-cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.

Xiao-Jun HuangY HongY QinY XuY ChangY WangX ZhangL XuX Huang
Published in: International journal of laboratory hematology (2017)
We are the first to demonstrate the reliability of the SIL-TAL1 fusion gene as a good MRD marker for patients with T-ALL after allo-HSCT.
Keyphrases
  • allogeneic hematopoietic stem cell transplantation
  • acute lymphoblastic leukemia
  • acute myeloid leukemia
  • copy number
  • genome wide
  • poor prognosis
  • gene expression
  • genome wide analysis
  • binding protein